Novartis has added two more mobile apps to its existing constellation of digital offerings. This time, cancer patients are the beneficiaries. The Swiss drugmaker rolled out an app to help oncology patients find appropriate clinical trials and an app specifically for patients with neuroendocrine tumors (NET).
The clinical-trials search tool already has some Big Pharma competition. Eli Lilly for one, offers its own version, FierceBiotechIT notes. The app for NET patients is a different stuff. It’s the sort of disease-management app that’s increasingly common in the diabetes field but less so in cancer.
Sanofi recently launched a text-based program for men with prostate cancer to push lifestyle tips and coping techniques to patients on chemo. My NET Manager is a full-fledged app that allows patients to log their symptoms, set reminders for treatment appointments and drug refills, and track their test results. Not coincidentally, Novartis markets Afinitor as a NET treatment, though the new app doesn’t directly promote the drug.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.